** = Publications listed in SCI/SSCI/Pubmed
** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Krassnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
BRIT J HAEMATOL. 2023; 201: 21-22.-63rd Annual Scientific Meeting of the British-Society-for-Haematology; APR 23-25, 2023; Birmingham, ENGLAND.
[Poster]
Web of Science
** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Kraßnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies.
Open Forum Infect Dis. 2022; 9(8): ofac393
Doi: 10.1093/ofid/ofac393
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14):
Doi: 10.3390/ijms23147874
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prochazka, KT; Uhl, B
Bcl2 inhibitor venetoclax +/- Anti-CD20: what do deep remissions mean?
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-021-00778-2
Web of Science
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Fechter, K; Pansy, K; Greinix, HT; Neumeister, P; Deutsch, AJ
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.
World J Gastrointest Oncol. 2022; 14(1): 153-162.
Doi: 10.4251/wjgo.v14.i1.153
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT
Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142.
[Poster]
Web of Science
FullText
** Monch, A; Prochazka, K; Greinix, H; Neumeister, P; Deutsch, A; Uhl, B
Specific clinical, serologic, and histopathologic Parameters are associated with inferior Survival of Patients with primary CNS Lymphoma
ONCOL RES TREAT. 2022; 45(SUPPL 2):61-61.
[Poster]
Web of Science
** Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA
The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946.
Doi: 10.1182/blood-2022-166678
[Poster]
Web of Science
FullText
FullText_MUG
** Berg, JL; Perfler, B; Hatzl, S; Mayer, MC; Wurm, S; Uhl, B; Reinisch, A; Klymiuk, I; Tierling, S; Pregartner, G; Bachmaier, G; Berghold, A; Geissler, K; Pichler, M; Hoefler, G; Strobl, H; Wölfler, A; Sill, H; Zebisch, A
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Clin Epigenetics. 2021; 13(1): 1-1.
Doi: 10.1186/s13148-020-00979-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Berg, JL; Perfler, B; Hatzl, S; Uhl, B; Reinisch, A; Pregartner, G; Berghold, A; Penz, T; Schuster, M; Geissler, K; Prokesch, A; Müller-Tidow, C; Hoefler, G; Kashofer, K; Wölfler, A; Sill, H; Caraffini, V; Zebisch, A
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Leukemia. 2021; 35(5):1521-1526
Doi: 10.1038/s41375-021-01161-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207
Doi: 10.1007/s00520-021-06059-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742
Doi: 10.3389/fimmu.2021.803742
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Halwachs, B; Bayer, N; Huber-Krassnitzer, B; Schulz, E; Uhl, B; Gaksch, L; Hatzl, S; Bachmayr, V; Kleissl, L; Kump, P; Deutsch, A; Stary, G; Greinix, H; Gorkiewicz, G; Högenauer, C; Neumeister, P
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
Ther Adv Hematol. 2021; 12:20406207211058333
Doi: 10.1177/20406207211058333
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pansy, K; Uhl, B; Krstic, J; Szmyra, M; Fechter, K; Santiso, A; Thüminger, L; Greinix, H; Kargl, J; Prochazka, K; Feichtinger, J; Deutsch, AJ
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Int J Mol Sci. 2021; 22(24):
Doi: 10.3390/ijms222413311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Perfler, B; Wurm, S; Uhl, B; Quehenberger, F; Ebner, S; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.
Cancers (Basel). 2020; 12(2):
Doi: 10.3390/cancers12020496
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zebisch, A; Winter, G; Kashofer, K; Hatzl, S; Uhl, B; Wurm, S; Wölfler, A; Greinix, HT; Hoefler, G; Sill, H
The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2020; 55(7):1502-1505
Doi: 10.1038/s41409-019-0691-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19):
Doi: 10.3390/ijms20194740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bärnthaler, T; Jandl, K; Sill, H; Uhl, B; Schreiber, Y; Grill, M; Thomas, D; Schicho, R; Marsche, G; Frank, S; Heinemann, A; Schuligoi, R
Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation.
J Allergy Clin Immunol. 2019; 143(2):794-797
Doi: 10.1016/j.jaci.2018.09.030
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A
Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82.
[Poster]
Web of Science
** Spindelbock, W; Huber-Krassnitzer, B; Uhl, B; Gorkiewicz, G; Greinix, H; Hogenauer, C; Neumeister, P
Treatment of acute refractory gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2019; 54: 294-295.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Poster]
Web of Science
** Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A
Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83.
[Poster]
Web of Science
** Caraffini, V; Perfler, B; Berg, JL; Uhl, B; Schauer, S; Kashofer, K; Ghaffari-Tabrizi-Wizsy, N; Strobl, H; Wölfler, A; Hoefler, G; Sill, H; Zebisch, A
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.
Blood. 2018; 131(7): 826-830.
Doi: 10.1182/blood-2017-09-804906
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Uhl, B; Hinterramskogler, M; Leber, S; Eisner, F; Haring, M; Jud, P
Acute myeloid leukemia with severe coagulation disorder and concomitant central nervous system bleeding - a clinical diagnostic case report.
EJIFCC. 2018; 29(2): 146-151.
(- Case Report)
[OPEN ACCESS]
PubMed
** Spindelboeck, W; Schulz, E; Uhl, B; Kashofer, K; Aigelsreiter, A; Zinke-Cerwenka, W; Mulabecirovic, A; Kump, PK; Halwachs, B; Gorkiewicz, G; Sill, H; Greinix, H; Högenauer, C; Neumeister, P
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.
Haematologica. 2017; 102(5):e210-e213-e210-e213
Doi: 10.3324/haematol.2016.154351
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG